Gilead Sciences

Cognizant has announced an expansion of its relationship with biopharmaceutical company Gilead Sciences. Under the agreement, Cognizant will manage Gilead’s global IT infrastructure, platforms, applications and advanced analytics and lead initiatives designed to accelerate its digital transformation. The agreement includes renewal and expansion of Cognizant services for a total expected value of $800 million over…

Cognizant on July 24 announced that its existing biopharmaceutical client Gilead Sciences has extended its partnership with the IT services major in a $800-million deal for the next five years. The collaboration with the North American company to streamline its businesses comes at a time when IT companies are staring at an uncertain demand environment…

Cognizant on Monday announced the expansion of its relationship with biopharmaceutical company Gilead Sciences for an additional five years, including renewal and expansion of Cognizant's services, for a total expected value of $800 million.Under the agreement, the NASDAQ-listed IT firm will manage Gilead’s global IT infrastructure, platforms, applications and advanced analytics, and lead initiatives to…

A New York Times report highlights an alleged plan at Gilead to delay the release of a promising new HIV drug to maximize profits. Separately, GSK was given marketing authorization for an HIV prevention drug in Europe. Other industry news concerns cosmetics research, industry deals and more. The New York Times: How Gilead Profited By Slow-Walking…

Cognizant will manage Gilead's global IT infrastructure while leading digital transformation initiatives designed to enhance overall client experience and enable faster time to market for Gilead products. TEANECK, N.J. , July 24, 2023 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced an expansion of its relationship with Gilead Sciences (NASDAQ: GILD). Gilead is a…

Cognizant expanded its relationship with Gilead Sciences to manage Gilead's global IT infrastructure, platforms, applications and advanced analytics, and lead initiatives designed to accelerate its digital transformation. The agreement includes renewal and expansion of Cognizant services for a total expected value of $800 million over the next five years. The collaboration is aimed at enabling Gilead to…

The focus of this collaboration is to streamline various aspects of Gilead's business, with the ultimate goal of reducing the time it takes to bring essential medicines to market, , cognizant, gilead sciences

Pacer Advisors Inc. lifted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 33.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,493,442 shares of the biopharmaceutical company's stock after purchasing an additional 867,597 shares during the period.…

Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) was the target of a large increase in short interest in June. As of June 30th, there was short interest totalling 17,340,000 shares, an increase of 6.3% from the June 15th total of 16,320,000 shares. Based on an average daily volume of 5,500,000 shares, the days-to-cover ratio…

Despite the major decline in COVID-19 vaccine sales since the 2022 peak, the infectious disease market is still expected to grow by 5.7% through 2029 with Pfizer, Gilead Sciences and GSK all set to | Despite the major decline in COVID-19 vaccine sales since the 2022 peak, the infectious disease market is still expected to…

State of Michigan Retirement System boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 0.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 372,243 shares of the biopharmaceutical company's stock after buying an additional 1,500 shares during the…

VMLY&R’s bid to clean up again at the Cannes Lions International Festival of Creativity is backed by a new collaborator: generative AI. | VMLY&R’s bid to clean up again at the Cannes Lions International Festival of Creativity is backed by a new collaborator: generative AI. Using the hyped technology, the marketing and comms agency has…